Addition of bevacizumab or sunitinib to biweekly cetuximab and irinotecan as salvage therapy in patients with metastatic colorectal cancer after failure to CetIri

Per Pfeiffer, Trine Lembrecht Jørgensen, Benny Vittrup Jensen, Camilla Qvortrup, K Skougaard, Jon Kroll Bjerregaard, Tine Plato Hansen, Estrid Høgdal, Dorte Nielsen

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskning

OriginalsprogEngelsk
Publikationsdato2009
StatusUdgivet - 2009
Begivenhed2009 ASCO Annual Meeting - Orlando, USA
Varighed: 29. maj 20092. jun. 2009

Konference

Konference2009 ASCO Annual Meeting
LandUSA
ByOrlando
Periode29/05/200902/06/2009

Citationsformater